SAA1 and rheumatoid arthritis: Serum amyloid A (SAA), a major acute-phase protein and inflammatory marker, has long been implicated as a predictor of clinical progression and outcome in RA [12] and a predictor of coronary artery disease, CV outcome [13], and early mortality in acute coronary syndromes [14].